Show results for
Refine by
Transplanter Equipment Supplied In France
19 equipment items found
Manufactured by:ELITechGroup based inPuteaux, FRANCE
Epstein-Barr Virus (EBV) is a widespread herpesvirus, generally asymptomatic or sometimes responsible for mild infection like mononucleosis. After solid organ or hematopoietic stem cell transplant, EBV reactivation is a common cause of malignant transformation, called Post-Transplant Lymphoproliferative Disorder “PTLD”. EBV viral load monitoring is ...
Manufactured by:ACS Biotech based inVilleurbanne, FRANCE
ACS Biotech has developed a cartilage repair product based on the chondrocyte transplantation ...
Manufactured by:Noraker based inLyon, FRANCE
Fixloop +, ligament attachment system provides an optimal solution for adjustable trans-osseous fixation of the transplant for the ligament reconstruction. This medical device is an alternative to the interference ...
Manufactured by:Noraker based inLyon, FRANCE
Fixloop, ligament attachment system provides an optimal solution for adjustable trans-osseous fixation of the transplant for the ligament reconstruction. This medical device is an alternative to the interference ...
Manufactured by:ELITechGroup based inPuteaux, FRANCE
Aspergillosis is the most common cause of fungal infection among stem cell and solid organ transplant recipients, resulting in high mortality if untreated. Patients with weakened immune system and lung diseases are at higher risk of developing severe outcomes. Early detection and quantification of Aspergillus with molecular methods is crucial to isolate infected patients and ...
Manufactured by:Carmat based inImmeuble l’Etendard, FRANCE
More specifically, Carmat aims to provide a lasting solution for the treatment of terminal heart failure, a disease for which there are very few effective options today, the main one being heart ...
Manufactured by:BioCydex based inPoitiers, FRANCE
Vectisol® is dedicated to the preservation of organs, tissues and cells. This molecular complex limits the deleterious effects of the ischemia-reperfusion ...
Manufactured by:Infomed SA based inMeinier, SWITZERLAND
TPE allows to remove patient’s plasma from the blood and to replace it with fluids which do not contain the large substances, such as antibodies, targeted to be removed. It applies to a wide range of acute diseases but more rarely to chronic ones due to the adverse effects of the replacement fluids, human albumin or fresh frozen plasma, ...
by:Treefrog Therapeutics based inPessac, FRANCE
$100,000 Funding: We fund your research over 2 years in the academic lab of your choice. You spend the money how you like on your project, so that you can give it your best shot. Just Science: Any PhD level scientist can apply anonymously by submitting a one-page research rationale and a graphical abstract. We select ideas, not resumes. No Hassle: The application process is fast. We don’t ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
OSE’s R&D team and its academic partners have characterized the myeloid checkpoint CLEC-1 (a C-type lectin receptor) as a new therapeutic target in immuno-oncology and identified monoclonal antibody antagonists blocking this novel “Don’t Eat Me” signal. CLEC-1 antagonist monoclonal antibodies have been identified as an innovative cancer immunotherapy that releases the ...
Manufactured by:Glaukos Corporation based inSan Clemente, CALIFORNIA (USA)
iLink is the first and only FDA-approved corneal cross-linking procedure that slows or halts the progression of keratoconus and helps preserve vision. Watch this video for unique patient and doctor perspectives about progressive keratoconus and learn how the condition is treated with iLink™ corneal cross-linking. ...
Manufactured by:Infomed SA based inMeinier, SWITZERLAND
Like TPE, cascade filtration and DFPP allow to remove the larger substances from the blood, such as antibodies, fibrinogen or LDL-cholesterol. Its interest remains in the fact that the plasma is filtered and then returned to the patient, avoiding or minimizing the need for replacement fluids. Thus, cascade filtration/DFPP applies to both acute and chronic ...
Manufactured by:ACS Biotech based inVilleurbanne, FRANCE
Cartilage defects can result either from an accident (car, sport ...) or from a degenerative disease such as osteoarthritis, rheumatoid arthritis or ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
a monoclonal antibody fragment and CD28 antagonist, selectively blunts CD28 co-stimulation while sparing the CTLA-4 co-inhibitory signal. The net effect of CD28 antagonism is down regulating effector T-cells while promoting T-Reg activity. The CD28/CTLA-4 pathway controls both T-cell activation and regulatory T-cell down regulation. CD28 receptor is expressed on the surface of the majority of ...
Manufactured by:CorWave based inClichy, FRANCE
The wave generated on this membrane moves from the outside to the inside of the disc, radially, propelling blood towards the central orifice. CorWave LVAD is an LVAD with a unique, physiological behaviour. It is intended to treat patients with advanced heart failure, and aims to reduce the risk of complications associated with current LVADs. ...
by:Treefrog Therapeutics based inPessac, FRANCE
C-Stem™ is a biomimetic cell culture technology allowing for the mass-production of stem cell- derived therapies with unprecedented cell quality, while cutting manufacturing costs by 10x. ...
Manufactured by:ELITechGroup based inPuteaux, FRANCE
Pneumocystis pneumonia (PCP) is an opportunistic disease caused by invasion of the unicellular fungus Pneumocystis jirovecii (PJ). In lungs PJ exists in trophic and cystis form and it is one of the most frequent and severe opportunistic infections in people with weakened immune systems. PCP a major cause of morbidity and mortality among HIV-infected patient, nowadays reduced with ART, moreover, ...
Manufactured by:ELITechGroup based inPuteaux, FRANCE
ELITe InGenius is an easy-to-use sample-to-result solution dedicated to Molecular Diagnostics which integrates extraction, amplification and result interpretation with an unprecedented flexibility and assay menu ...
Manufactured by:CellProthera based inMulhouse, FRANCE
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to mobilize the patient’s own stem cells into the blood flow. The patient’s blood sample is then forwarded to a local certified Cell Therapy ...